Make cancer treatment more effective and tolerable
Personalized prescription guidance for chemotherapy and supportive care medications
Pharmacogenomic (PGx) testing is emerging as a valuable tool to help guide prescription decisions in oncology. OneOme's RightMed® test is a PGx test that analyzes a patient's DNA to determine which medications and dosages may work best, providing valuable information to guide chemotherapy and supportive care decisions. The test covers medications commonly used in cancer care, including medications for chemotherapy, nausea/vomiting, pain, depression, anxiety, sleep, and more.
The RightMed test and the supporting RightMed oncology report may help you to more quickly identify the right medication or dose for a patient, leading to fewer adverse reactions, less trial and error, and more effective treatments.
Get a Sample RightMed oncology report
The Sample RightMed oncology report includes:
- Both chemotherapies and palliative/supportive care medications, sorted by type of medication
- Sample test results showing how medications are classified based on the severity of the predicted gene-drug interaction
- A sample gene and phenotype summary for genes associated with the medications on the report
The RightMed test: Helping oncology patients get the right treatment or dose
The RightMed test covers hundreds of medications, including chemotherapies and supportive care medications. The RightMed oncology report includes medications relevant to oncology, grouped by category of drug and predicted gene-drug interaction (major, moderate, minimal). Providers also get access to relevant clinical guidelines, curated medication alternatives, and consults with OneOme's clinical team.
HOW THE RIGHTMED TEST MAY HELP WITH PERSONALIZED CHEMOTHERAPY DOSING
The RightMed test provides recommendations for specific chemotherapy dose adjustments to prevent toxicity and risk of side effects, based on a patient’s genes.
The RightMed test covers several chemotherapies commonly used for breast cancer, colorectal cancer, lung cancer, blood cancers, and more. The test includes both first-line therapies as well as several targeted therapies, also known as the tyrosine kinase receptor inhibitors (TKIs).
For a list of chemotherapy agents covered on the RightMed test download our Guide to the RightMed test for oncology.
HOW THE RIGHTMED TEST MAY HELP WITH SUPPORTIVE CARE
The RightMed test covers many medications often prescribed for an oncology patient’s supportive care, including medications for pain, nausea, vomiting, sleep, hypertension, anxiety, depression, infection prophylaxis, and more.
By using the RightMed comprehensive test when prescribing medications for comorbidities, you may be able to find the right medication and dose faster, reduce the number of adverse drug reactions, and make your patients more comfortable.
For a list of supportive care conditions covered on the RightMed test download our Guide to the RightMed test for oncology.
The benefits of the RightMed test
The RightMed test can benefit providers, health systems, and patients by:
Reducing adverse
drug reactions
improve patient
adherence
improve
health and
economic cost
effectiveness
optimize dosing
change the
prescribing
paradigm from
reactive
to preventive
RightMed patient story
“The RightMed test results, for me, mean that I don’t have to be anxious or scared going into a procedure.”
— Pam
Read Pam's full story >
